{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:49:59Z","timestamp":1778863799950,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A sense of loss of control over eating, such that eating occurs despite the intent not to, is common in people with obesity and eating disorders such as binge eating disorder and bulimia nervosa. Currently, options for management of loss of control eating are limited. We recently determined that the pro-drug N-acetylcysteine (NAC) reduces compulsive-like eating in a rat model of diet-induced obesity. We will now conduct a single site, open-label pilot study to examine the feasibility of a randomized controlled trial (RCT) of NAC for loss of control eating in humans.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Thirty-six adult volunteers with loss of control eating will be enrolled. All participants will receive NAC at a dose of 1200\u00a0mg orally twice daily for 12\u00a0weeks. Eating behaviors and triggers will be assessed before and after the NAC treatment period using questionnaires (Eating Loss of Control Scale, Palatable Eating Motives Scale: Coping Subscale, Food Craving Inventory, Reward-Based Eating Scale, Perceived Stress Scale, and Emotional Eating Scale) and ecological momentary assessment (EMA). The primary outcomes of this feasibility study are recruitment rate, participant retention rate at week 12, and medication adherence. The secondary outcome is change in Eating Loss of Control Scale score from baseline to week 12. Exploratory data will be collected on the change in eating behaviors from baseline to week 12. Although EMA can provide real-time data on eating behaviors compared with retrospective questionnaires, it relies on repeated daily measurement for long periods which can affect participant\u2019s adherence to study protocol. Therefore, this feasibility study will assess the performance of EMA versus retrospective questionnaires and will determine which approach suits the purposes of the research.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The results of this study will inform the feasibility of a RCT of NAC for loss of control eating using EMA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>This study was prospectively registered with the Australian and New Zealand Clinical Trials Registry in June 2022 (ACTRN12622000902796).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40814-025-01598-5","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:10:11Z","timestamp":1739959811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the utility of N-acetylcysteine for loss of control eating: protocol of an open-label single-arm pilot study"],"prefix":"10.1186","volume":"11","author":[{"given":"Muthmainah","family":"Muthmainah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Sketriene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta G.","family":"Anversa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gogos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Sumithran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-3634","authenticated-orcid":false,"given":"Robyn M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"1598_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2021.100941","volume":"63","author":"RG Anversa","year":"2021","unstructured":"Anversa RG, et al. A review of sex differences in the mechanisms and drivers of overeating. Front Neuroendocrinol. 2021;63: 100941.","journal-title":"Front Neuroendocrinol"},{"issue":"1742","key":"1598_CR2","doi-asserted-by":"publisher","first-page":"20170024","DOI":"10.1098\/rstb.2017.0024","volume":"373","author":"CF Moore","year":"2018","unstructured":"Moore CF, et al. Neuropharmacology of compulsive eating. Philos Trans R Soc Lond B Biol Sci. 2018;373(1742):20170024.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1598_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eatbeh.2015.12.007","volume":"21","author":"AM Chao","year":"2016","unstructured":"Chao AM, et al. Food craving, binge eating, and eating disorder psychopathology: exploring the moderating roles of gender and race. Eat Behav. 2016;21:41\u20137.","journal-title":"Eat Behav"},{"issue":"2","key":"1598_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4088\/JCP.08m04328blu","volume":"71","author":"MA White","year":"2010","unstructured":"White MA, et al. Loss of control over eating predicts outcomes in bariatric surgery patients: a prospective, 24-month follow-up study. J Clin Psychiatry. 2010;71(2):175\u201384.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"1598_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/obr.12491","volume":"18","author":"AB Goldschmidt","year":"2017","unstructured":"Goldschmidt AB. Are loss of control while eating and overeating valid constructs? A critical review of the literature. Obes Rev. 2017;18(4):412\u201349.","journal-title":"Obes Rev"},{"issue":"3","key":"1598_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/erv.2583","volume":"26","author":"SM Manasse","year":"2018","unstructured":"Manasse SM, et al. Are individuals with loss-of-control eating more prone to dietary lapse in behavioural weight loss treatment? An ecological momentary assessment study. Eur Eat Disord Rev. 2018;26(3):259\u201364.","journal-title":"Eur Eat Disord Rev"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fpsyt.2014.00164","volume":"5","author":"MN Potenza","year":"2014","unstructured":"Potenza MN, Grilo CM. How relevant is food craving to obesity and its treatment? Front Psychiatry. 2014;5:164.","journal-title":"Front Psychiatry"},{"key":"1598_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnins.2017.00469","volume":"11","author":"CF Moore","year":"2017","unstructured":"Moore CF, et al. Neuroscience of compulsive eating behavior. Front Neurosci. 2017;11:469.","journal-title":"Front Neurosci"},{"issue":"12","key":"1598_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/13543784.2019.1692813","volume":"28","author":"JC Appolinario","year":"2019","unstructured":"Appolinario JC, Nardi AE, McElroy SL. Investigational drugs for the treatment of binge eating disorder (BED): an update. Expert Opin Investig Drugs. 2019;28(12):1081\u201394.","journal-title":"Expert Opin Investig Drugs"},{"key":"1598_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/JEP.S255376","volume":"13","author":"MN Levitan","year":"2021","unstructured":"Levitan MN, et al. Binge eating disorder: a 5-year retrospective study on experimental drugs. J Exp Pharmacol. 2021;13:33\u201347.","journal-title":"J Exp Pharmacol"},{"issue":"1","key":"1598_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clinthera.2020.10.014","volume":"43","author":"RG Boswell","year":"2021","unstructured":"Boswell RG, Potenza MN, Grilo CM. The neurobiology of binge-eating disorder compared with obesity: implications for differential therapeutics. Clin Ther. 2021;43(1):50\u201369.","journal-title":"Clin Ther"},{"issue":"10","key":"1598_CR12","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1517\/14656566.2015.1053465","volume":"16","author":"DL Reas","year":"2015","unstructured":"Reas DL, Grilo CM. Pharmacological treatment of binge eating disorder: update review and synthesis. Expert Opin Pharmacother. 2015;16(10):1463\u201378.","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"1598_CR13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","volume":"61","author":"SL McElroy","year":"2007","unstructured":"McElroy SL, et al. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry. 2007;61(9):1039\u201348.","journal-title":"Biol Psychiatry"},{"key":"1598_CR14","doi-asserted-by":"crossref","unstructured":"Nourredine M., et al., Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis. CNS Spectr. 2021;26(5):459\u201367.","DOI":"10.1017\/S1092852920001613"},{"issue":"9","key":"1598_CR15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.4088\/JCP.v68n0901","volume":"68","author":"AM Claudino","year":"2007","unstructured":"Claudino AM, et al. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J Clin Psychiatry. 2007;68(9):1324\u201332.","journal-title":"J Clin Psychiatry"},{"key":"1598_CR16","doi-asserted-by":"crossref","unstructured":"Deepmala, et al., Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294\u2013321.","DOI":"10.1016\/j.neubiorev.2015.04.015"},{"issue":"1","key":"1598_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/YCO.0000000000000017","volume":"27","author":"C Kariuki-Nyuthe","year":"2014","unstructured":"Kariuki-Nyuthe C, Gomez-Mancilla B, Stein DJ. Obsessive compulsive disorder and the glutamatergic system. Curr Opin Psychiatry. 2014;27(1):32\u20137.","journal-title":"Curr Opin Psychiatry"},{"issue":"9","key":"1598_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamapsychiatry.2013.2207","volume":"70","author":"RM Brown","year":"2013","unstructured":"Brown RM, Kupchik YM, Kalivas PW. The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy. JAMA Psychiat. 2013;70(9):895\u20137.","journal-title":"JAMA Psychiat"},{"issue":"3","key":"1598_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1124\/pr.110.003889","volume":"64","author":"R Bridges","year":"2012","unstructured":"Bridges R, et al. Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev. 2012;64(3):780\u2013802.","journal-title":"Pharmacol Rev"},{"issue":"10","key":"1598_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","volume":"65","author":"LA Knackstedt","year":"2009","unstructured":"Knackstedt LA, et al. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009;65(10):841\u20135.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1598_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","volume":"67","author":"LA Knackstedt","year":"2010","unstructured":"Knackstedt LA, Melendez RI, Kalivas PW. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry. 2010;67(1):81\u20134.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"1598_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.neuroscience.2008.06.010","volume":"155","author":"KS Kau","year":"2008","unstructured":"Kau KS, et al. Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking. Neuroscience. 2008;155(2):530\u20137.","journal-title":"Neuroscience"},{"issue":"7","key":"1598_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nn1069","volume":"6","author":"DA Baker","year":"2003","unstructured":"Baker DA, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6(7):743\u20139.","journal-title":"Nat Neurosci"},{"issue":"51","key":"1598_CR24","doi-asserted-by":"publisher","first-page":"13968","DOI":"10.1523\/JNEUROSCI.2808-07.2007","volume":"27","author":"A Madayag","year":"2007","unstructured":"Madayag A, et al. Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. J Neurosci. 2007;27(51):13968\u201376.","journal-title":"J Neurosci"},{"issue":"4","key":"1598_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/npp.2010.226","volume":"36","author":"SL Amen","year":"2011","unstructured":"Amen SL, et al. Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans. Neuropsychopharmacology. 2011;36(4):871\u20138.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1598_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/adb.12127","volume":"20","author":"KJ Reissner","year":"2015","unstructured":"Reissner KJ, et al. Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement. Addict Biol. 2015;20(2):316\u201323.","journal-title":"Addict Biol"},{"issue":"27","key":"1598_CR27","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","volume":"25","author":"MM Moran","year":"2005","unstructured":"Moran MM, et al. Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci. 2005;25(27):6389\u201393.","journal-title":"J Neurosci"},{"issue":"2","key":"1598_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","volume":"31","author":"PN Mardikian","year":"2007","unstructured":"Mardikian PN, et al. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):389\u201394.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"1598_CR29","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1111\/ejn.15321","volume":"54","author":"D Sketriene","year":"2021","unstructured":"Sketriene D, et al. N-acetylcysteine reduces addiction-like behaviour towards high-fat high-sugar food in diet-induced obese rats. Eur J Neurosci. 2021;54(3):4877\u201387.","journal-title":"Eur J Neurosci"},{"issue":"7","key":"1598_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/ijo.2016.31","volume":"40","author":"MM Hurley","year":"2016","unstructured":"Hurley MM, et al. N-acetylcysteine decreases binge eating in a rodent model. Int J Obes (Lond). 2016;40(7):1183\u20136.","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"1598_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00213-012-2837-3","volume":"225","author":"AM Ramirez-Ni\u00f1o","year":"2013","unstructured":"Ramirez-Ni\u00f1o AM, D\u2019Souza MS, Markou A. N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking. Psychopharmacology. 2013;225(2):473\u201382.","journal-title":"Psychopharmacology"},{"issue":"1","key":"1598_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.eatbeh.2012.11.001","volume":"14","author":"AI Guerdjikova","year":"2013","unstructured":"Guerdjikova AI, et al. N-acetylcysteine in bulimia nervosa\u2013open-label trial. Eat Behav. 2013;14(1):87\u20139.","journal-title":"Eat Behav"},{"issue":"1","key":"1598_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1037\/a0034729","volume":"26","author":"KK Blomquist","year":"2014","unstructured":"Blomquist KK, et al. Development and validation of the eating loss of control scale. Psychol Assess. 2014;26(1):77\u201389.","journal-title":"Psychol Assess"},{"issue":"9","key":"1598_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/eat.22741","volume":"50","author":"LB Shomaker","year":"2017","unstructured":"Shomaker LB, et al. A randomized, comparative pilot trial of family-based interpersonal psychotherapy for reducing psychosocial symptoms, disordered-eating, and excess weight gain in at-risk preadolescents with loss-of-control-eating. Int J Eat Disord. 2017;50(9):1084\u201394.","journal-title":"Int J Eat Disord"},{"key":"1598_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.eatbeh.2018.03.005","volume":"29","author":"RW Goode","year":"2018","unstructured":"Goode RW, et al. The feasibility of a binge eating intervention in Black women with obesity. Eat Behav. 2018;29:83\u201390.","journal-title":"Eat Behav"},{"issue":"1","key":"1598_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40337-022-00674-y","volume":"10","author":"AR Keshen","year":"2022","unstructured":"Keshen AR, et al. Effect of stimulant medication on loss of control eating in youth with attention deficit\/hyperactivity disorder: a prospective, observational case series study protocol. J Eat Disord. 2022;10(1):152.","journal-title":"J Eat Disord"},{"key":"1598_CR37","unstructured":"ClinicalTrials.gov, Cognitive behavioural therapy for adolescent binge eating and loss of control eating. NCT04088097. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04088097"},{"issue":"1","key":"1598_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40814-021-00770-x","volume":"7","author":"M Lewis","year":"2021","unstructured":"Lewis M, et al. Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back: Pilot Feasibility Stud. 2021;7(1):40.","journal-title":"Pilot Feasibility Stud."},{"issue":"3","key":"1598_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","volume":"42","author":"K Thompson","year":"2000","unstructured":"Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241\u20137.","journal-title":"Schizophr Res"},{"key":"1598_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.appet.2013.09.016","volume":"72","author":"EE Burgess","year":"2014","unstructured":"Burgess EE, et al. Profiling motives behind hedonic eating. Preliminary validation of the Palatable Eating Motives Scale. Appetite. 2014;72:66\u201372.","journal-title":"Appetite"},{"issue":"2","key":"1598_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/oby.2002.17","volume":"10","author":"MA White","year":"2002","unstructured":"White MA, et al. Development and validation of the food-craving inventory. Obes Res. 2002;10(2):107\u201314.","journal-title":"Obes Res"},{"key":"1598_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3389\/fpsyg.2017.00795","volume":"8","author":"AE Mason","year":"2017","unstructured":"Mason AE, et al. Improving assessment of the spectrum of reward-related eating: the RED-13. Front Psychol. 2017;8:795.","journal-title":"Front Psychol"},{"issue":"4","key":"1598_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385\u201396.","journal-title":"J Health Soc Behav"},{"issue":"1","key":"1598_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/1098-108X(199507)18:1<79::AID-EAT2260180109>3.0.CO;2-V","volume":"18","author":"B Arnow","year":"1995","unstructured":"Arnow B, Kenardy J, Agras WS. The Emotional Eating Scale: the development of a measure to assess coping with negative affect by eating. Int J Eat Disord. 1995;18(1):79\u201390.","journal-title":"Int J Eat Disord"},{"issue":"6","key":"1598_CR45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/eat.22401","volume":"48","author":"KC Berg","year":"2015","unstructured":"Berg KC, et al. Negative affect prior to and following overeating-only, loss of control eating-only, and binge eating episodes in obese adults. Int J Eat Disord. 2015;48(6):641\u201353.","journal-title":"Int J Eat Disord"},{"issue":"6","key":"1598_CR46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/YCO.0000000000000639","volume":"33","author":"LM Schaefer","year":"2020","unstructured":"Schaefer LM, Engel SG, Wonderlich SA. Ecological momentary assessment in eating disorders research: recent findings and promising new directions. Curr Opin Psychiatry. 2020;33(6):528\u201333.","journal-title":"Curr Opin Psychiatry"},{"key":"1598_CR47","doi-asserted-by":"crossref","unstructured":"Bos, F.M., R.A. Schoevers, and M. aan het Rot, Experience sampling and ecological momentary assessment studies in psychopharmacology: a systematic review. Eur Neuropsychopharmacol, 2015;25(11): 1853\u201364.","DOI":"10.1016\/j.euroneuro.2015.08.008"},{"issue":"3","key":"1598_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.euroneuro.2010.11.004","volume":"21","author":"N Geschwind","year":"2011","unstructured":"Geschwind N, et al. Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy. Eur Neuropsychopharmacol. 2011;21(3):241\u20137.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"1598_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pbb.2011.02.021","volume":"98","author":"JG Gehricke","year":"2011","unstructured":"Gehricke JG, et al. ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD. Pharmacol Biochem Behav. 2011;98(3):485\u201391.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"1598_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s41687-020-00261-2","volume":"4","author":"TH Oreel","year":"2020","unstructured":"Oreel TH, et al. Ecological momentary assessment versus retrospective assessment for measuring change in health-related quality of life following cardiac intervention. J Patient Rep Outcomes. 2020;4(1):98.","journal-title":"J Patient Rep Outcomes"},{"key":"1598_CR51","doi-asserted-by":"publisher","unstructured":"Jean, FA.M., et al., Feasibility and validity of Ecological Momentary Assessment in patients with acute coronary syndrome. BMC Cardiovasc Disord, 2020; 20(1): 499. https:\/\/doi.org\/10.1186\/s12872-020-01774-w.","DOI":"10.1186\/s12872-020-01774-w"},{"key":"1598_CR52","doi-asserted-by":"publisher","unstructured":"Moitra, E., et al., Feasibility and acceptability of post-hospitalization ecological momentary assessment in patients with psychotic-spectrum disorders. Compr Psychiatry, 2017;74:204\u2013213. https:\/\/doi.org\/10.1016\/j.comppsych.2017.01.018","DOI":"10.1016\/j.comppsych.2017.01.018"},{"key":"1598_CR53","doi-asserted-by":"publisher","unstructured":"Kirk GD, et al. The exposure assessment in current time study: implementation, feasibility, and acceptability of real-time data collection in a community cohort of illicit drug users. AIDS Res Treat, 2013; 2013: 594671. https:\/\/doi.org\/10.1155\/2013\/594671.","DOI":"10.1155\/2013\/594671"},{"issue":"4","key":"1598_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000327682","volume":"17","author":"L Schmaal","year":"2011","unstructured":"Schmaal L, et al. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. Eur Addict Res. 2011;17(4):211\u20136.","journal-title":"Eur Addict Res"},{"key":"1598_CR55","volume-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"2013","unstructured":"APA. Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: American Psychiatric Press; 2013.","edition":"5"},{"key":"1598_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neubiorev.2016.01.013","volume":"63","author":"RM Kessler","year":"2016","unstructured":"Kessler RM, et al. The neurobiological basis of binge-eating disorder. Neurosci Biobehav Rev. 2016;63:223\u201338.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"1598_CR57","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1017\/S1368980013000591","volume":"17","author":"GV de Fran\u00e7a","year":"2014","unstructured":"de Fran\u00e7a GV, Gigante DP, Olinto MT. Binge eating in adults: prevalence and association with obesity, poor self-rated health status and body dissatisfaction. Public Health Nutr. 2014;17(4):932\u20138.","journal-title":"Public Health Nutr"},{"issue":"10","key":"1598_CR58","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/oby.21607","volume":"24","author":"V Ivezaj","year":"2016","unstructured":"Ivezaj V, White MA, Grilo CM. Examining binge-eating disorder and food addiction in adults with overweight and obesity. Obesity (Silver Spring). 2016;24(10):2064\u20139.","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"1598_CR59","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","volume":"73","author":"RC Kessler","year":"2013","unstructured":"Kessler RC, et al. The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry. 2013;73(9):904\u201314.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1598_CR60","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.appet.2011.08.017","volume":"57","author":"C Davis","year":"2011","unstructured":"Davis C, et al. Evidence that \u201cfood addiction\u201d is a valid phenotype of obesity. Appetite. 2011;57(3):711\u20137.","journal-title":"Appetite"},{"issue":"2","key":"1598_CR61","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.appet.2008.12.003","volume":"52","author":"AN Gearhardt","year":"2009","unstructured":"Gearhardt AN, Corbin WR, Brownell KD. Preliminary validation of the Yale Food Addiction Scale. Appetite. 2009;52(2):430\u20136.","journal-title":"Appetite"},{"issue":"1","key":"1598_CR62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1037\/adb0000136","volume":"30","author":"AN Gearhardt","year":"2016","unstructured":"Gearhardt AN, Corbin WR, Brownell KD. Development of the Yale Food Addiction Scale Version 20. Psychol Addict Behav. 2016;30(1):113\u201321.","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"1598_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/idoj.IDOJ_475_18","volume":"10","author":"B Nair","year":"2019","unstructured":"Nair B. Clinical trial designs. Indian Dermatol Online J. 2019;10(2):193\u2013201. https:\/\/doi.org\/10.4103\/idoj.IDOJ_475_18.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"1598_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/qhc.12.1.47","volume":"12","author":"M Eccles","year":"2003","unstructured":"Eccles M, et al. Research designs for studies evaluating the effectiveness of change and improvement strategies. BMJ Qual Saf. 2003;12(1):47\u201352.","journal-title":"BMJ Qual Saf"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-025-01598-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:12:14Z","timestamp":1739959934000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-025-01598-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1186\/s40814-025-01598-5","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been prospectively registered with the Australian and New Zealand Clinical Trials Registry (Trial registration: ACTRN12622000902796) and approved by the University of Melbourne human research ethics committee (HREC), Reference Number: 2022\u201322812-35644\u20138. This study will be conducted in compliance with Australia\u2019s National Statement on Ethical Conduct in Human Research. Any change to the protocol document or informed consent form that affects the scientific intent, study design, or participant safety will be submitted to the HREC for approval prior to being implemented. Institutional governance authorisation for the research and associated HREC-approved documents is provided by the Florey Institute of Neuroscience and Mental Health. Participants will be required to provide written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PS has co-authored manuscripts with medical writing assistance provided by Novo Nordisk and Eli Lilly. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}